1. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy;Aschele;J Clin Oncol,1999
2. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute;Christian;Semin Oncol,1997
3. A phase III multicenter randomized trial comparing CPT-11 to supportive care (SC) alone in patients (pts) with 5-FU-resistant metastatic colorectal cancer (MCRC);Cunningham;Proceedings of the American Society of Clinical Oncology,1998
4. Final results of a randomised trial comparing Tomudex (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer: Tomudex Colorectal Cancer Study Group;Cunningham;Ann Oncol,1996
5. A randomized trial of leucovorin (LV) and 5-fluorouracil (5-FU) with or without oxaliplatin in advanced colorectal cancer (CRC);De Gramont;Proceedings of the American Society of Clinical Oncologists,1998